Peking University People'S Hospital
Beijing, Beijing Municipality, +86-010, China
NCT Number: NCT03840655
T3/T4 endoscopic thoracic sympathicotomy is a widely accepted and effective treatment for primary palmar hyperhidrosis. However, sympathetic ganglions are invisible with traditional thoracoscopy and until now, the location of ganglions are confirmed by rib indirectly. The team from thoracic department of Peking University People's Hospital discovered that the sympathetic ganglions can be visualized with fluorescent thoracoscopy. Thus, investigators want to apply fluorescent thoracoscopy in sympathicotomy of palmar hyperhidrosis, to conduct a more precise operation and compare the efficiency of the novel and traditional methods.
Looking for future studies?
Notify Me16 year–75 year
All sexes
Observational
Beijing, Beijing Municipality, +86-010, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sympathicotomy performed by near-infrared imaging thoracoscopy
Time frame: during surgery
Record the spatial relationship between sympathetic ganglions and ribs, for example: T3/R4 represents the T3 sympathetic ganglion is located on the 4th rib.
Time frame: 1 month after surgery
Use questionnaire including 3 descriptive names of scale ( over dry, comfortable and wet) to record the surgical effect on palmar sweating.
Time frame: 1 month after surgery
Use questionnaire including 4 descriptive names of scale ( none, mild, moderate and severe) to record the side effect (compensatory hyperhidrosis) of this surgery.
Peking University People's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06731101
Palmar Hyperhidrosis
Al Fayyum, Egypt
View Trial DetailsNCT03880266
Palmar Hyperhidrosis
Encinitas, California, United States
View Trial DetailsNCT04906655
Hyperhidrosis, Palmar Hyperhidrosis
Norfolk, Virginia, United States
View Trial DetailsNCT03404570
Palmar Hyperhidrosis
San Diego, California, United States
View Trial Details